Recommendations Provided for Treatment of Ulcerative Colitis
Infliximab, adalimumab, golimumab, vedolizumab, tofacitinib, ustekinumab recommended over no tx
Short-Term Medications May Cut Risk for ‘Broken Heart’ Syndrome
Combination of low-dose β-blocker and aspirin may reduce heightened CV risk in early bereavement
Considerable Increase Seen in List, Net Prices of Branded Drugs
From 2007 to 2018, list prices increased 159 percent, while net prices increased by 60 percent
Serum Folate Tied to CV Mortality Risk in Rheumatoid Arthritis
Serum folate levels above 4.3 ng/mL tied to lower cardiovascular mortality with rheumatoid arthritis
Racial/Ethnic Insurance Coverage Disparity Down Since ACA
From 2013 to 2017, drop seen in unadjusted, adjusted black-white gap, Hispanic-white gap in uninsurance
Molecularly Matched Therapy Promising in Pancreatic Cancer
Overall survival significantly longer for patients with actionable molecular alterations receiving matched tx
Smartphone Use Linked to Increased Meds Required for Headache
Higher proportion of patients using smartphones taking analgesics, getting less relief with medication
EHR Use Up in Residential Care Communities 2012 to 2016
Increase seen in computerized support for health information exchange with physicians or pharmacists
Use of PPIs Tied to Cognitive Issues in Breast Cancer Survivors
Concentration, memory problems reported in breast cancer patients at different stages of survivorship
Evidence Lacking for Pharmacologic Therapy for Cannabis Use Disorder
Several drug classes including cannabinoids, SSRIs seem to be ineffective for cannabis use disorder
